Saved in:
| Main Author: | Cao, Yihai |
|---|---|
| Format: | Recurso digital |
| Language: | English |
| Published: |
Zenodo
2024
|
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s44178-024-00077-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Associations of metabolic phenotypes with cardiac structure, and clinical outcomes: insights from the UK Biobank
by: Bogner, Balazs, et al.
Published: (2025)
by: Bogner, Balazs, et al.
Published: (2025)
Journal of Cachexia, Sarcopenia and Muscle
Published: (2016)
Published: (2016)
CHEMOTHERAPY FOR ELDERLY PATIENTS WITH GASTRIC CANCER: EXPERIENCE OF A BRAZILIAN CENTER
by: Pedro Aguiar Jr
Published: (2016)
by: Pedro Aguiar Jr
Published: (2016)
JCSM Communications
Published: (2025)
Published: (2025)
JCSM Rapid Communications
Published: (2020)
Published: (2020)
The Heterogeneity of Cancer Metabolism
Published: (2021)
Published: (2021)
Endocannabinoid receptor 2 is a potential biomarker and therapeutic target for the lysosomal storage disorders
by: Calogera M. Simonaro, et al.
Published: (2024)
by: Calogera M. Simonaro, et al.
Published: (2024)
From Ethnobotany to Immunometabolism: Network Pharmacology Analysis of Nigerian Medicinal Plants as Modulators of Immune-Metabolic Pathways in Obesity and Type 2 Diabetes
by: Jesutofunmi Adeyemi Samson
Published: (2026)
by: Jesutofunmi Adeyemi Samson
Published: (2026)
Exploring RNA therapeutics for urea cycle disorders
by: Eva Richard, et al.
Published: (2024)
by: Eva Richard, et al.
Published: (2024)
Physiology of acid-base balance in bovines with diarrhea backgrounds from Monteria, Colombia
by: César Betancur H
Published: (2015)
by: César Betancur H
Published: (2015)
Therapeutic Advances in Endocrinology and Metabolism
Published: (2019)
Published: (2019)
Potential therapeutic uses of L‐citrulline beyond genetic urea cycle disorders
by: Marshall Summar
Published: (2024)
by: Marshall Summar
Published: (2024)
Exploration of Endocrine and Metabolic Diseases
Published: (2026)
Published: (2026)
Endocrinology Insights
Published: (2025)
Published: (2025)
Brain morphometry in hepatic Wilson disease patients
by: Parya Rahimi, et al.
Published: (2024)
by: Parya Rahimi, et al.
Published: (2024)
Unifying biology of neurodegeneration in lysosomal storage diseases
by: Anna M. Ludlaim, et al.
Published: (2025)
by: Anna M. Ludlaim, et al.
Published: (2025)
Cellular mechanisms of acute rhabdomyolysis in inherited metabolic diseases
by: Hortense de Calbiac, et al.
Published: (2024)
by: Hortense de Calbiac, et al.
Published: (2024)
Liver‐directed gene therapy for inherited metabolic diseases
by: Julien Baruteau, et al.
Published: (2024)
by: Julien Baruteau, et al.
Published: (2024)
Mission possible: Gene therapy for inherited metabolic diseases
by: Julien Baruteau, et al.
Published: (2024)
by: Julien Baruteau, et al.
Published: (2024)
Neuronopathic Gaucher disease: Rare in the West, common in the East
by: Ozlem Goker‐Alpan, et al.
Published: (2024)
by: Ozlem Goker‐Alpan, et al.
Published: (2024)
A 6‐month randomized controlled trial for vitamin E supplementation in pediatric patients with Gaucher disease: Effect on oxidative stress, disease severity and hepatic complications
by: Amira Abdel Moneam Adly, et al.
Published: (2024)
by: Amira Abdel Moneam Adly, et al.
Published: (2024)
What can pediatricians learn from adult inherited metabolic diseases?
by: Fanny Mochel
Published: (2024)
by: Fanny Mochel
Published: (2024)
Comparative analysis of gene and disease selection in genomic newborn screening studies
by: Isabel R. Betzler, et al.
Published: (2024)
by: Isabel R. Betzler, et al.
Published: (2024)
Diabetes & Metabolism Journal
Published: (2016)
Published: (2016)
Endocrine and Metabolic Science
Published: (2021)
Published: (2021)
Uncommon case of mitochondrial disease: Mild amyotrophy of the legs and symmetrical lipomatosis of the arms
by: Leslie Bercu, et al.
Published: (2024)
by: Leslie Bercu, et al.
Published: (2024)
Epidemiology and economic burden of Wilson disease in France: A nationwide population‐based study
by: Shona Fang, et al.
Published: (2024)
by: Shona Fang, et al.
Published: (2024)
Natural history of valve disease in patients with mucopolysaccharidosis II and the impact of enzyme replacement therapy
by: Christoph Kampmann, et al.
Published: (2024)
by: Christoph Kampmann, et al.
Published: (2024)
Executive and adaptive function impacts long‐term outcomes for adults with maple syrup urine disease
by: Jessica I. Gold, et al.
Published: (2024)
by: Jessica I. Gold, et al.
Published: (2024)
Parental and child's psychosocial and financial burden living with an inherited metabolic disease identified by newborn screening
by: Elena Schnabel‐Besson, et al.
Published: (2024)
by: Elena Schnabel‐Besson, et al.
Published: (2024)
The PompeQoL questionnaire: Development and validation of a new measure for children and adolescents with Pompe disease
by: Moritz Ilan Truninger, et al.
Published: (2024)
by: Moritz Ilan Truninger, et al.
Published: (2024)
Regulatory news: Cipaglucosidase alfa‐atga (Pombiliti) coadministered with Miglustat (Opfolda) for adults with late‐onset Pompe disease
by: Daniela V. Luquetti, et al.
Published: (2024)
by: Daniela V. Luquetti, et al.
Published: (2024)
Natural disease course of chronic visceral acid sphingomyelinase deficiency in adults: A first step toward treatment criteria
by: Eline C. B. Eskes, et al.
Published: (2024)
by: Eline C. B. Eskes, et al.
Published: (2024)
Integration of multi‐omics layers empowers precision diagnosis through unveiling pathogenic mechanisms on maple syrup urine disease
by: Juan Ramón Tejedor, et al.
Published: (2024)
by: Juan Ramón Tejedor, et al.
Published: (2024)
Current global vitamin and cofactor prescribing practices for primary mitochondrial diseases: Results of a European reference network survey
by: Julia Neugebauer, et al.
Published: (2024)
by: Julia Neugebauer, et al.
Published: (2024)
Repurposing empagliflozin in individuals with glycogen storage disease Ib: A value‐based healthcare approach and systematic benefit‐risk assessment
by: Terry G. J. Derks, et al.
Published: (2024)
by: Terry G. J. Derks, et al.
Published: (2024)
Long term survival in patients with classic infantile Pompe disease reveals a spectrum with progressive brain abnormalities and changes in cognitive functioning
by: J. J. A. van den Dorpel, et al.
Published: (2024)
by: J. J. A. van den Dorpel, et al.
Published: (2024)
Use of pure recombinant human enzymes to assess the disease‐causing potential of missense mutations in urea cycle disorders, applied to N‐acetylglutamate synthase deficiency
by: Nadine Gougeard, et al.
Published: (2024)
by: Nadine Gougeard, et al.
Published: (2024)
A phase III, open‐label clinical trial evaluating pegunigalsidase alfa administered every 4 weeks in adults with Fabry disease previously treated with other enzyme replacement therapies
by: Myrl Holida, et al.
Published: (2024)
by: Myrl Holida, et al.
Published: (2024)
Mass cytometry reveals atypical immune profile notably impaired maturation of memory CD4 T with Gb3‐related CD27 expression in CD4 T cells in Fabry disease
by: Wladimir Mauhin, et al.
Published: (2024)
by: Wladimir Mauhin, et al.
Published: (2024)
Similar Items
-
Associations of metabolic phenotypes with cardiac structure, and clinical outcomes: insights from the UK Biobank
by: Bogner, Balazs, et al.
Published: (2025) -
Journal of Cachexia, Sarcopenia and Muscle
Published: (2016) -
CHEMOTHERAPY FOR ELDERLY PATIENTS WITH GASTRIC CANCER: EXPERIENCE OF A BRAZILIAN CENTER
by: Pedro Aguiar Jr
Published: (2016) -
JCSM Communications
Published: (2025) -
JCSM Rapid Communications
Published: (2020)